Skip to main content

Hyro AI

Category: AI in Healthcare

An adaptive conversational AI platform that automates patient communications for healthcare organizations using natural language understanding. Hyro AI was founded in 2018. The company is led by Israel Krush. Based in New York, NY, USA (HQ); Tel Aviv, Israel (R&D). Team size: 51-100. Total funding raised: $50M. Latest round: Series B Extension. Key investors include ["Healthier Capital","Macquarie Capital","Hanaco Ventures","Spero Ventures","Mindset Ventures","Twilio Ventures","Liberty Mutual Strategic Ventures","Black Opal Ventures"].

Founded
2018
Headquarters
New York, NY, USA (HQ); Tel Aviv, Israel (R&D)
Team size
51-100
Total funding
$50M

Value proposition

Automates high-volume patient interactions across voice, text, and web to improve access to care, enhance patient experience, and reduce administrative staff burden.

Products and solutions

["Adaptive Communications Platform (omni-channel conversational assistant)","Call Center Automation (voice-based virtual agents)","Patient Self-Service Tools (digital front door solutions)"]

Unique value

Hyro's core innovation is its 'Adaptive Communications' technology, which uses a proprietary Natural Language Understanding (NLU) engine that does not require pre-defined scripts or manual training data, enabling rapid and scalable deployment.

Target customer

Large healthcare providers, hospital systems, clinics, payers, and telehealth companies.

Industries served

["Healthcare (Providers and Payers)","Government/Public Sector"]

Technology advantage

A plug-and-play NLU engine that automatically ingests an organization's data (from websites, databases, etc.) to build and maintain conversational flows, combined with seamless integration with major EHRs like Epic and Cerner.

How they differentiate

Hyro differentiates through its zero-training, adaptive NLU for faster deployment, a focus on adaptive conversational flows over rigid rule-based bots, and deep, plug-and-play integrations into complex hospital workflows and EHRs.

Main competitors

["Nuance Communications (Microsoft)","Notable Health","Orbita Inc."]

Key partnerships

["Epic Systems (App Orchard Partner)","Leading health systems like Intermountain Health and Novant Health"]

Notable customers

["Intermountain Health","Montefiore Medical Center","Novant Health","Weill Cornell Medicine","Mercy Health"]

Major milestones

["Named to CB Insights' 'Top Digital Health Startups' list.","Recognized in Gartner Hype Cycle reports for Healthcare Providers.","Secured official partnership/integration status with the Epic App Orchard.","Closed a Series B extension in December 2024, increasing total funding to $50 million."]

Growth metrics

Deployed at over two dozen major U.S. hospital networks; ARR doubled year-over-year (FY23-FY24); handles millions of patient interactions annually.

Market positioning

Positioned as a premium, enterprise-grade solution for large-scale U.S. healthcare providers seeking sophisticated automation without a heavy IT implementation burden.

Geographic focus

Primarily North America, with plans for expansion into the UK and EU markets.

Patents and IP

Proprietary technology is core to their differentiation, but no public record of granted patents is available.

About Israel Krush

Israel Krush is the CEO and Co-Founder of Hyro AI. He has a background in computer science and has held leadership positions at various technology companies, including Head of Product at Zeekit (acquired by Walmart). His experience in both engineering and product management, combined with his service in the Israeli intelligence unit 8200, has provided him with a strong foundation for leading an AI-driven company.

Official website: